Brennan Katherine 4

What Happened Katherine Brennan, SVP and General Counsel of Marsh & McLennan Companies (MRSH), received an award of 5,963 restricted stock units (RSUs) on 2026-05-01. The grant is reported as a derivative award at $0.00 per unit (total reported value $0 at grant). These RSUs convert to common stock on a 1-for-1 basis and vest over three years.

Key Details

• Transaction date and price: 2026-05-01; 5,963 RSUs @ $0.00 (derivative award).
• Vesting: Three equal annual installments on May 15, 2027, 2028 and 2029 (Footnote F2).
• Conversion: RSUs convert to Marsh & McLennan common stock on a 1-for-1 basis (Footnote F1).
• Shares owned after transaction: Not disclosed in the provided filing.
• Filing: Reported on 2026-05-01; no indication in this filing of a late report (no timeliness flag shown).
• Other footnotes: F3 listed as Not Applicable.

Context RSUs are a form of compensation that convert to actual shares only when they vest; they do not require an upfront cash purchase by the insider and do not represent immediate share sales. Such grants are routine executive compensation and should be interpreted as part of pay, not a direct market buy or sell signal.